Lgt Group Foundation Eli Lilly & CO Transaction History

Lgt Group Foundation

$7.78 Billion
Q2 2025

A detailed history of Lgt Group Foundation transactions in Eli Lilly & CO stock. As of the latest transaction made, Lgt Group Foundation holds 472,480 shares of LLY stock, worth $387 Million. This represents 4.73% of its overall portfolio holdings.

Number of Shares

472,480

Previous 442,388 6.8%

Holding current value

$387 Million

Previous $365 Million 0.8%

% of portfolio

4.73%

Previous 5.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$713.71 - $898.95 $21.5 Million - $27.1 Million	30,092 Added 6.8%	472,480 $368 Million
Q1 2025 May 13, 2025	BUY	$725.72 - $929.72 $69.2 Million - $88.6 Million	95,348 Added 27.47%	442,388 $365 Million
Q4 2024 Feb 06, 2025	BUY	$727.2 - $932.06 $31.9 Million - $40.9 Million	43,884 Added 14.48%	347,040 $268 Million
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $70.6 Million - $87.7 Million	-91,397 Reduced 23.16%	303,156 $269 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $181 Million - $227 Million	249,272 Added 171.58%	394,553 $357 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $42.1 Million - $56.3 Million	-71,041 Reduced 32.84%	145,281 $113 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $1.67 Million - $1.97 Million	-3,182 Reduced 1.45%	216,322 $126 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $920,694 - $1.27 Million	-2,118 Reduced 0.96%	219,504 $118 Million
Q2 2023 Jul 27, 2023	BUY	$350.74 - $468.98 $1.38 Million - $1.84 Million	3,921 Added 1.8%	221,622 $104 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $3.86 Million - $4.53 Million	-12,430 Reduced 5.4%	217,701 $74.8 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $13.9 Million - $16.2 Million	43,198 Added 23.11%	230,131 $84.2 Million
Q3 2022 Oct 19, 2022	SELL	$296.48 - $337.87 $7.12 Million - $8.11 Million	-24,013 Reduced 11.38%	186,933 $60.4 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $13.3 Million - $15.6 Million	47,816 Added 29.31%	210,946 $68.4 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $10.1 Million - $12.6 Million	43,046 Added 35.85%	163,130 $47.7 Million
Q4 2021 May 03, 2022	BUY	$224.85 - $279.04 $27 Million - $33.5 Million	120,084 New	120,084 $33.2 Million

Others Institutions Holding LLY

# of Institutions

4,448

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.

Account

Lgt Group Foundation Eli Lilly & CO Transaction History